Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."
"We urge Congress to pass final legislation that reflects this approach and retains ACR-backed provisions that can save lives," CEO Dana Smetherman, MD, MPH, MBA, said Sept. 10.
Founded in 2011 and based in Belgium, the AI firm offers the first software for automating brain assessments needed to administer disease therapies from Biogen and Eli Lilly.
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Jamieson M. Bourque, MD, MHS, president-elect of the American Society of Nuclear Cardiology, shared the group's concerns with Cardiovascular Business. “This is going to have a highly negative impact," he said.
Consolidation of image interpretation assistance into one package can minimize costs and open the market to radiology providers who cannot afford current offerings, scientists write in Radiology.
IRs can play a key role in kidney care using a novel, nonsurgical approach that deploys catheters and imaging guidance to create a fistula in the arm for dialysis access.
One imaging policy expert called this stance from ACR and ASRT a “devastating blow” to physician offices and independent diagnostic testing facilities who use virtual supervision for Medicare patients.
Founded in 2006 by Don and Dave Specht, the Arizona company’s computed “echo tomography” product uses sound waves to cross through body barriers for “rapid and effective imaging.”
Alan Matsumoto, MD, chair of the American College of Radiology, explains ACR support for the Radiology Outpatient Ordering Transmission (ROOT) Act in Congress.
Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."
Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly.
Jamieson M. Bourque, MD, MHS, president-elect of the American Society of Nuclear Cardiology, shared the group's concerns with Cardiovascular Business. “This is going to have a highly negative impact," he said.
